Intervention Studies
The IMPACT Collaboratory is actively working on a variety of efforts to address COVID-19 pandemic. We are pleased to announce that members of the IMPACT community have been awarded 4 NIA COVID-19 Supplements for research efforts in response to the urgent public health needs arising from COVID-19 and it’s devastating impact on people living with dementia and their families and caregivers.
Principal Investigator
Sarah Berry, MD, MPH
Marcus Institute for Aging Research, Hebrew SeniorLife
Principal Investigator
Vince Mor, PhD
Brown University School of Public Health
- IMPACT researchers explore differences in COVID-19 vaccine brand usage by rural/urban demographics
A team of researchers, including IMPACT members Daniel Harris, PhD, Ellen McCarthy, PhD, MPH, and Vincent Mor, PhD, examined geographic variations in the use of Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines among Medicare beneficiaries throughout the US. Using a novel data set including CVS Health and Walgreens pharmacy customers linked to Medicare claims for vaccine administration, the team uncovered large county-level variation in vaccine use across the US. One notable finding was the predominance of Pfizer-BioNTech vaccines in urban areas, contrasted with the higher utilization of Moderna vaccines in rural regions. The authors discuss the individual and public health implications of differential distribution of Pfizer-BioNTech and Moderna vaccines across US counties.
May 2024
- COVID-19 Serology Strategies in Skilled Nursing Facilities (CERO)
